Answered step by step
Verified Expert Solution
Question
1 Approved Answer
The accompanying data file contains information on 186 terminally ill patients who agreed to participate in a new drug trial. They were randomly assigned to
The accompanying data file contains information on 186 terminally ill patients who agreed to participate in a new drug trial. They were randomly assigned to either an experimental group or a control group. Patients in the experimental group were given the new drug that is being tested for this particular illness. Patients in the control group were kept on the medicine they had been receiving. After one year, it was noted whether or not the patient was still alive.Click here for the Excel Data Filea-1. Construct a contingency table that cross-classifies the data by Experimental_Drug and Living. Provide the frequencies in the accompanying data file.a-2. How many of the patients received the experimental drug?a-3. How many of the patients were still living after one year?b-1. Of the patients in the control group, what proportion was still living after one year?Note: Report the proportion rounded to 2 decimal places.b-2. Of the patients in the experimental group, what proportion was still living after one year?Note: Report the proportion rounded to 2 decimal places. https://ezt.prod.mheducation.com/Media/Connect_Production/bne/Jaggia_Ess_3e/using_r/excel_data_file/ch02/static/Ch02_Q35_Data_File.xlsx
Patient | Experimental_Drug | Living |
1 | Yes | Yes |
2 | Yes | Yes |
3 | Yes | No |
4 | No | No |
5 | Yes | No |
6 | Yes | Yes |
7 | Yes | Yes |
8 | Yes | Yes |
9 | Yes | No |
10 | Yes | No |
11 | Yes | Yes |
12 | No | Yes |
13 | Yes | Yes |
14 | Yes | Yes |
15 | Yes | Yes |
16 | Yes | No |
17 | No | Yes |
18 | Yes | No |
19 | Yes | Yes |
20 | No | No |
21 | Yes | Yes |
22 | Yes | Yes |
23 | No | Yes |
24 | No | No |
25 | Yes | No |
26 | No | No |
27 | No | No |
28 | No | Yes |
29 | No | No |
30 | No | Yes |
31 | Yes | No |
32 | No | No |
33 | Yes | Yes |
34 | No | Yes |
35 | No | No |
36 | No | Yes |
37 | Yes | Yes |
38 | Yes | Yes |
39 | Yes | No |
40 | No | Yes |
41 | No | No |
42 | Yes | Yes |
43 | Yes | No |
44 | No | Yes |
45 | Yes | Yes |
46 | No | No |
47 | Yes | Yes |
48 | No | Yes |
49 | Yes | Yes |
50 | Yes | Yes |
51 | Yes | Yes |
52 | Yes | Yes |
53 | No | No |
54 | Yes | Yes |
55 | No | Yes |
56 | Yes | No |
57 | Yes | Yes |
58 | No | Yes |
59 | No | Yes |
60 | Yes | Yes |
61 | No | Yes |
62 | Yes | Yes |
63 | No | Yes |
64 | No | Yes |
65 | No | No |
66 | No | No |
67 | No | Yes |
68 | No | No |
69 | Yes | Yes |
70 | Yes | Yes |
71 | Yes | Yes |
72 | Yes | No |
73 | Yes | Yes |
74 | Yes | No |
75 | Yes | Yes |
76 | Yes | Yes |
77 | No | Yes |
78 | No | Yes |
79 | No | Yes |
80 | Yes | Yes |
81 | No | No |
82 | Yes | No |
83 | No | No |
84 | Yes | Yes |
85 | No | Yes |
86 | No | Yes |
87 | Yes | No |
88 | Yes | No |
89 | Yes | Yes |
90 | Yes | No |
91 | Yes | Yes |
92 | No | Yes |
93 | No | No |
94 | No | No |
95 | No | Yes |
96 | No | Yes |
97 | Yes | Yes |
98 | Yes | Yes |
99 | No | No |
100 | No | No |
101 | No | Yes |
102 | No | Yes |
103 | Yes | Yes |
104 | No | Yes |
105 | Yes | Yes |
106 | No | No |
107 | Yes | Yes |
108 | Yes | Yes |
109 | Yes | Yes |
110 | Yes | Yes |
111 | No | Yes |
112 | Yes | Yes |
113 | Yes | Yes |
114 | Yes | No |
115 | Yes | Yes |
116 | No | No |
117 | No | Yes |
118 | No | Yes |
119 | Yes | No |
120 | No | No |
121 | No | Yes |
122 | Yes | No |
123 | Yes | No |
124 | Yes | No |
125 | Yes | Yes |
126 | Yes | Yes |
127 | Yes | Yes |
128 | Yes | Yes |
129 | No | No |
130 | No | Yes |
131 | No | No |
132 | Yes | Yes |
133 | Yes | No |
134 | No | No |
135 | Yes | Yes |
136 | No | No |
137 | Yes | No |
138 | Yes | Yes |
139 | Yes | Yes |
140 | No | No |
141 | No | Yes |
142 | Yes | Yes |
143 | Yes | Yes |
144 | No | Yes |
145 | No | Yes |
146 | No | No |
147 | Yes | No |
148 | No | Yes |
149 | No | Yes |
150 | No | Yes |
151 | No | No |
152 | No | Yes |
153 | No | Yes |
154 | No | Yes |
155 | Yes | No |
156 | No | No |
157 | No | No |
158 | No | Yes |
159 | Yes | No |
160 | No | No |
161 | No | Yes |
162 | No | No |
163 | No | No |
164 | No | Yes |
165 | Yes | Yes |
166 | No | Yes |
167 | No | Yes |
168 | Yes | No |
169 | Yes | No |
170 | Yes | No |
171 | Yes | Yes |
172 | Yes | Yes |
173 | Yes | Yes |
174 | No | No |
175 | No | Yes |
176 | Yes | Yes |
177 | Yes | Yes |
178 | Yes | No |
179 | Yes | Yes |
180 | Yes | Yes |
181 | No | Yes |
182 | Yes | Yes |
183 | No | No |
184 | Yes | Yes |
185 | Yes | Yes |
186 | Yes | No |
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Step 1 Construct the Contingency Table ExperimentalDrug vs Living We categorize the data into four g...Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started